Dexamethasone for Severe COVID Pneumonia: What Does the Data Show?
July 24, 2020
Pharmacy Podcast Network
Overinflamation or cytokine storm is said to be the driver of acute respiratory disorder disease (ARDS) in COVID patients. A recent study conducted in the United Kingdom suggests that the steroid dexamethasone may be a weapon for prevention. In this episode, we discuss the study that caused the National Health Service in the U.K. and the CDC to change their recommendations for steroids and severe COVID.Additional Resources/ReferencesRamdomised Evaluation of COVID-19 Therapy: https://www.recoverytrial.net/ This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/3h8OfTR See omnystudio.com/listener for privacy information.
Follow CEimpact on Social Media:
Download the CEimpact App for Free Continuing Education + so much more!